Search Results - "Costalunga, Alessandra"

Cyclosporine A in Reperfused Myocardial Infarction by Ottani, Filippo, MD, Latini, Roberto, MD, Staszewsky, Lidia, MD, La Vecchia, Luigi, MD, Locuratolo, Nicola, MD, Sicuro, Marco, MD, Masson, Serge, PhD, Barlera, Simona, MS, Milani, Valentina, PhD, Lombardi, Mario, MD, Costalunga, Alessandra, MD, Mollichelli, Nadia, MD, Santarelli, Andrea, MD, De Cesare, Nicoletta, MD, Sganzerla, Paolo, MD, Boi, Alberto, MD, Maggioni, Aldo Pietro, MD, Limbruno, Ugo, MD

“…Abstract Background Whether cyclosporine A (CsA) has beneficial effects in reperfused myocardial infarction (MI) is debated. Objectives This study investigated…”
Get full text

Cyclosporine A in Reperfused Myocardial Infarction: The Multicenter, Controlled, Open-Label CYCLE Trial by Ottani, Filippo, Latini, Roberto, Staszewsky, Lidia, La Vecchia, Luigi, Locuratolo, Nicola, Sicuro, Marco, Masson, Serge, Barlera, Simona, Milani, Valentina, Lombardi, Mario, Costalunga, Alessandra, Mollichelli, Nadia, Santarelli, Andrea, De Cesare, Nicoletta, Sganzerla, Paolo, Boi, Alberto, Maggioni, Aldo Pietro, Limbruno, Ugo

“…Whether cyclosporine A (CsA) has beneficial effects in reperfused myocardial infarction (MI) is debated. This study investigated whether CsA improved…”
Get full text

Outcomes following primary percutaneous coronary intervention for unprotected left main-related ST-segment elevation myocardial infarction by Ielasi, Alfonso, Silvestro, Antonio, Personeni, Davide, Saino, Antonio, Angeletti, Chiara, Costalunga, Alessandra, Tespili, Maurizio

“…INTRODUCTIONUnprotected left main (ULM) related ST-segment elevation myocardial infarction (STEMI) is a severe event, often leading to circulatory failure…”
Get full text

Reproducibility in circadian rhythm of ventricular premature complexes by Lanza, Gaetano A., Cortellessa, Maria C., Rebuzzi, Antonio G., Scabbia, Enrico V., Costalunga, Alessandra, Tamburi, Sergio, Lucente, Michele, Manzoli, Ugo

“…To evaluate the existence and reproducibility of a circadian rhythm of ventricular premature complexes (VPCs), 38 patients (mean age 57 ± 17 years) with ≥30…”
Get full text

Primary percutaneous coronary intervention and therapeutic hypothermia in comatose survivors after out-of-hospital cardiac arrest complicating acute myocardial infarction: a single-center experience by Angeletti, Chiara, Ielasi, Alfonso, Personeni, Davide, Mamprin, Filippo, Silvestro, Antonio, Saino, Antonio, Bertocchi, Ester, Costalunga, Alessandra, Keim, Roberto, Tespili, Maurizio

“…Therapeutic hypothermia (TH) is associated with improved neurologic outcomes in comatose survivors of out-of-hospital cardiac arrest (OHCA). There are…”
Get more information

Treatment of refractory heart failure with a percutaneous circulatory support device by Mammana, Carmelo, Tespili, Maurizio, Costalunga, Alessandra, Jacovoni, Attilio, Veritti, Umbertina, Lorini, Luca, Ferrazzi, Paolo, Gavazzi, Antonello

“…End-stage heart failure refractory to medical therapy is a clinical challenge. Heart transplantation is considered the best strategy, but it remains burdened…”
Get full text

Color Doppler study of mitral regurgitation during percutaneous transluminal coronary angioplasty by Biasucci, L M, Lombardo, A, Rossi, E, Pennestri, F, Mongiardo, R, Mazzari, M, Alecce, G, Testa, M, Costalunga, A, Loperfido, F

“…Mitral regurgitation (MR) was evaluated by color Doppler echocardiography during percutaneous transluminal coronary angioplasty (PTCA) in 28 patients with…”
Get more information